Drug recall · February 21, 2024
Nortrel recall
Why: Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67
- Lots / codes
Lot #: 100042978, Exp 7/31/2024
- Quantity
- 12,916 cartons
- Company
- Teva Pharmaceuticals USA, Inc, Parsippany, NJ
- Distribution
- nationwide
- Initiated
- January 25, 2024 · Voluntary: Firm initiated
- Classified
- February 12, 2024
- Reported
- February 21, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ethinyl estradiol / norethindrone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.